Journal of Intensive and Critical Care Open Access

Therapeutic Approaches for Acute Kidney Dysfunction

Miguel Davi^* Department of Nephrology, University of Sao Paulo Medical School, Sao Paulo, Brazil
^*Correspondence: Miguel Davi, Department of Nephrology, University of Sao Paulo Medical School, Sao Paulo, Brazil, Email:

Received: 30-May-2025, Manuscript No. IPJICC-26-23806; Editor assigned: 02-Jun-2025, Pre QC No. IPJICC-26-23806 (PQ); Reviewed: 16-Jun-2025, QC No. IPJICC-26-23806; Revised: 21-Jun-2025, Manuscript No. IPJICC-26-23806 (R); Published: 30-Jun-2025, DOI: 10.36648/2471-8505.11.2.75

Description

Acute kidney injury represents a rapid decline in renal function that occurs over hours or days. The kidneys perform several essential tasks including filtration of metabolic waste, regulation of fluid balance and maintenance of electrolyte equilibrium. When kidney performance deteriorates, accumulation of nitrogenous waste products and disturbances in fluid and electrolyte balance may occur, creating serious complications in severely ill patients. Several mechanisms contribute to acute kidney injury. Reduced blood flow to the kidneys is one of the most common causes, often occurring during severe dehydration, systemic infection or cardiovascular instability. In such situations, inadequate perfusion limits the delivery of oxygen and nutrients to renal tissue. Cellular injury may follow, impairing filtration capacity. Direct toxicity from medications or metabolic disturbances can also affect renal cells and disrupt their ability to maintain normal filtration processes.

Early recognition plays an important role in successful management. Rising serum creatinine levels and declining urine output often signal the onset of kidney dysfunction. Clinicians also evaluate electrolyte concentrations and fluid status to determine the severity of impairment. Identifying the underlying cause guides treatment decisions and helps prevent further deterioration. Fluid management represents one of the first steps in treatment. In patients with reduced circulating volume, intravenous fluid administration improves renal perfusion and supports glomerular filtration. Careful assessment is required to avoid excessive fluid accumulation, particularly in individuals with cardiac or pulmonary limitations. Monitoring urine output provides valuable information about renal response to therapy. Medication management also influences recovery. Certain drugs may impair renal function or accumulate when kidney filtration declines. Dose adjustments or temporary discontinuation may be necessary to prevent toxicity. Additionally, medications that affect blood pressure or renal blood flow must be used cautiously in patients with compromised kidney function.

Electrolyte imbalance frequently accompanies acute kidney injury. Elevated potassium concentration is especially concerning because it can interfere with normal cardiac rhythm. Medical treatment may include agents that shift potassium into cells or enhance elimination. Sodium, calcium and phosphate levels also require monitoring and correction when necessary.

When kidney function declines to a level that cannot sustain metabolic balance, renal replacement therapy becomes necessary. Hemodialysis and continuous filtration techniques remove waste products and excess fluid from the bloodstream through specialized membranes. Continuous approaches are often used in severely ill patients because they provide gradual solute removal and maintain hemodynamic stability. Nutrition also plays an important role during recovery from kidney injury. Adequate caloric intake supports tissue repair and immune function, while protein intake must be carefully balanced to avoid excessive nitrogenous waste accumulation. Dietitians collaborate with medical teams to develop nutritional plans suited to the patient’s metabolic needs. Recovery from acute kidney injury varies widely among patients. Some individuals regain normal renal function within days, while others experience partial recovery or progression to chronic kidney disease. Continuous monitoring of kidney function during hospitalization and after discharge assists clinicians in detecting long-term complications.

Preventive strategies remain essential in high-risk populations. Adequate hydration, cautious medication use and early treatment of systemic infection reduce the likelihood of renal injury. In hospital settings, monitoring urine output and serum creatinine levels enables clinicians to detect subtle changes before severe impairment develops. Another important aspect of management involves maintaining stable blood pressure and adequate circulation. Reduced arterial pressure may compromise renal perfusion and worsen cellular injury. Physicians often adjust fluid therapy and medications carefully to maintain appropriate perfusion without causing fluid overload. Monitoring devices provide continuous information about cardiovascular status, enabling clinicians to adapt treatment as the patient’s condition evolves. Long-term follow-up is equally important after recovery from an acute episode. Even when kidney function appears to improve, subtle impairment may persist and increase the likelihood of chronic kidney disease later in life. Periodic evaluation of renal function, blood pressure control and lifestyle adjustments such as maintaining hydration and avoiding nephrotoxic medications support continued renal health. Regarding early symptoms and routine medical evaluation helps reduce the risk of recurrent injury. Acute kidney injury represents a complex condition that requires careful coordination of fluid management, electrolyte correction, medication adjustment and supportive therapy. Through timely recognition and comprehensive care, clinicians can improve outcomes and reduce long-term complications associated with renal dysfunction.

References

1. Truong E, Noureddin M. The interplay between nonalcoholic fatty liver disease and kidney disease. Clin Liv Dis. 2022;26(2):213-227. 

   [Crossref] [Google Scholar] [PubMed].

2. Targher G, Byrne CD. Non-alcoholic fatty liver disease: An emerging driving force in chronic kidney disease. Nat. Rev. Nephrol. 2017;13(5):297-310.

   [Crossref] [Google Scholar] [PubMed].

3. Bonavia A, Stiles N. Renohepatic crosstalk: A review of the effects of acute kidney injury on the liver. Nephrol. Dial. Transplant. 2022;37(7):1218-1228.

   [Crossref] [Google Scholar] [PubMed].

4. Mannion R, Fitzpatrick E. Systemic complications secondary to chronic liver disease. Indian J Pediatr. 2024;91(3):286-293.

   [Crossref] [Google Scholar] [PubMed].

5. Velez JC, Therapondos G, Juncos LA. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nat. Rev. Nephrol. 2020;16(3):137-155.

   [Crossref] [Google Scholar] [PubMed].

6. Fukazawa K, Lee HT. Updates on hepato-renal syndrome. J. Anesth. Clin. Res. 2013;4(9):352.

   [Crossref] [Google Scholar] [PubMed].

7. Le P, Tatar M, Dasarathy S, Alkhouri N, Herman WH, Taksler GB, et al. Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050. JAMA Netw Open. 2025;8(1):e2454707.

   [Crossref] [Google Scholar] [PubMed].

8. Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202-209.

   [Crossref] [Google Scholar] [PubMed].

9. Choe HJ, Moon JH, Kim W, Koo BK, Cho NH. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up. Metabolism. 2024;153:155800.

   [Crossref] [Google Scholar] [PubMed].

10. Manco M, Ciampalini P, DeVito R, Vania A, Cappa M, Nobili V. Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. Pediatr. Nephrol. 2009;24(6):1211-1217.

    [Crossref] [Google Scholar] [PubMed].